Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Open-Label, Chronic Exposure, Safety Study of CLONICEL (Clonidine HCl Sustained Release) in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)

ClinicalTrials.gov ID: NCT00723190

Public ClinicalTrials.gov record NCT00723190. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 12:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Chronic Exposure Evaluation of the Safety of CLONICEL (Clonidine HCl Sustained Release) in the Treatment of Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this 12-month, multi-center, open-label study is to evaluate the safety of CLONICEL (clonidine HCl sustained release) when administered chronically under regular clinical conditions either as monotherapy or in combination with stimulant therapy to children and adolescents with attention deficit hyperactivity disorder (ADHD).

Study identification

NCT ID
NCT00723190
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Shionogi
Industry
Enrollment
303 participants

Conditions and interventions

Eligibility (public fields only)

Age range
6 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2008 (Type not available)
Primary completion
Mar 2010 (Actual)
Completion
Jun 2010 (Actual)
Last update posted
Apr 18, 2018

2008 – 2010

United States locations

U.S. sites
27
U.S. states
14
U.S. cities
26
Facility City State ZIP Site status
Not listed Little Rock Arkansas 72205 —
Not listed El Centro California 92243 —
Not listed Irvine California 92612 —
Not listed San Diego California 92103 —
Not listed Bradenton Florida 34208 —
Not listed Gainesville Florida 32607 —
Not listed Jacksonville Florida 32216 —
Not listed Lauderhill Florida 33319 —
Not listed Miami Florida 33161 —
Not listed Orlando Florida 32806 —
Not listed Bardstown Kentucky 40004 —
Not listed Baltimore Maryland 21208 —
Not listed Rochester Hills Michigan 48307 —
Not listed St Louis Missouri 63005 —
Not listed Voorhees Township New Jersey 08043 —
Not listed Willingboro New Jersey 08046 —
Not listed Chapel Hill North Carolina 27514 —
Not listed Charlotte North Carolina 28209 —
Not listed Durham North Carolina 27705 —
Not listed Cleveland Ohio 44106 —
Not listed Oklahoma City Oklahoma 73103 —
Not listed Oklahoma City Oklahoma 73116 —
Not listed Houston Texas 77007 —
Not listed Lake Jackson Texas 77566 —
Not listed Wharton Texas 77488 —
Not listed Clinton Utah 84015 —
Not listed Kirkland Washington 98033 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00723190, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 18, 2018 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00723190 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →